Clin2
NCT07612293Possibly a fitNot yet recruiting

Removing part of the thyroid for early-stage medullary thyroid cancer

Thyroid Gland Medullary Carcinoma

Part of Cancer clinical trials.

This study compares two surgeries for early-stage medullary thyroid cancer: removing only the side of the thyroid with the tumor (lobectomy) versus removing the whole thyroid, both with removal of nearby lymph nodes. The goal is to see if the less extensive surgery can be just as effective with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be at least 18 years old
  • Have a diagnosis of medullary thyroid cancer (or test results strongly suggesting it)
  • Be healthy enough for surgery to remove part or all of the thyroid
  • Not have certain other thyroid conditions that make removing the whole thyroid necessary
  • Not have a genetic RET mutation (an inherited change that raises cancer risk)
  • Not have cancer spread to lymph nodes outside the treatment area

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03813173Not yet recruiting
Central neck lymph node removal for early thyroid cancer

This study compares two ways of removing lymph nodes in the central part of the neck during thyroid cancer surgery. The goal is to see which approach is safer and more effective for patients whose cancer hasn't spread to lymph nodes.

NCT06851260Not yet recruiting
Thymus-sparing technique for thyroid cancer surgery

This study tests whether a surgical technique that preserves the thymus during thyroid cancer removal can protect the parathyroid glands, which help control calcium levels. The goal is to reduce complications while still removing the cancer completely.

NCT06087068Recruiting· Phase 2
Thyroid hormone therapy after lobectomy for low-risk thyroid cancer

This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.

Beijing, Beijing Municipality
NCT06082180Recruiting· Phase 3
Preventive neck lymph node removal in low-risk thyroid cancer

This trial is for people with low-risk papillary thyroid cancer. It compares two surgical approaches: one that removes just the thyroid gland, and another that also removes some lymph nodes in the center of the neck as a preventive measure. The goal is to see if removing these lymph nodes helps prevent the cancer from coming back.

Beijing, Beijing Municipality
NCT05604963Recruiting
Half or full thyroid surgery for low-risk thyroid cancer

This study looks at people with low-risk thyroid cancer who have already had (or are about to have) surgery, comparing half-thyroid removal versus full-thyroid removal. It may help doctors choose the safest and most effective surgery for your cancer type and risk level.

Crewe, Cheshire
NCT07851324Not yet recruiting
Predicting lymph node spread in medullary thyroid cancer

This study looks at tissue samples from people who had surgery for medullary thyroid cancer to see if certain features can predict whether the cancer has spread to nearby lymph nodes. This could help doctors better plan treatment and avoid unnecessary surgeries in the future.

Hear when a new Thyroid Gland Medullary Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.